February 23, 2026|Client Alerts
Foreign Talent, Domestic Risk: Deemed Export Issues in Tech Hiring
By Kripa Upadhyay
Insights
February 23, 2026|Client Alerts
By Kripa Upadhyay
U.S. companies hiring foreign national talent in technology, artificial intelligence, advanced computing, semiconductor, and HealthTech sectors face a compliance risk that is often overlooked: deemed exports. In today’s regulatory environment—marked by heightened enforcement, geopolitical tensions, and rapid innovation—routine workplace access to controlled technology can trigger U.S. export licensing requirements. This risk exists even when no physical shipment occurs and no information leaves the United States.
For employers sponsoring H-1B, L-1, O-1, TN, F-1 OPT/STEM OPT, or J-1 workers, export compliance is no longer separate from immigration strategy — it is directly intertwined with it.
What Is a Deemed Export?
A deemed export occurs when controlled technology or source code is released to a foreign national within the United States. The U.S. government treats that release as an export to the individual’s country of citizenship.
Deemed exports are primarily regulated under:
Under these frameworks, providing a foreign national employee with access to controlled source code, technical schematics, encryption architecture, semiconductor fabrication processes, or certain AI model training parameters may require prior government authorization.
Why Technology, AI, and HealthTech Companies Face Elevated Risk
Emerging and dual-use technologies are a core focus of U.S. export enforcement policy. Companies operating in the following areas are particularly exposed:
Artificial Intelligence & Machine Learning
Advanced AI model design, training data frameworks with dual-use potential, and algorithmic architectures.
Semiconductor & Advanced Computing
Chip design IP, fabrication process flows, and electronic design automation (EDA) systems.
Encryption & Software
Proprietary source code, cryptographic systems, and cloud-based development environments.
HealthTech & Biotech
Genomic sequencing tools, advanced medical device prototypes, and controlled bio-manufacturing processes.
In many of these sectors, controlled technology may not appear obviously “military” in nature — but dual-use classifications can still apply, potentially triggering licensing obligations.
The Immigration Filing Trigger: H-1B Export Attestation
When filing an H-1B petition, employers must complete an export control certification within Form I-129. The employer must attest that:
This export attestation is not a formality — it creates a documented compliance representation to the U.S. government. Treating this step as a routine checkbox without a substantive regulatory analysis can expose the organization to enforcement risk.
Enforcement Trends & Penalties: What Clients Need to Know
Non-compliance with export control regulations carries significant civil, administrative, and criminal consequences. Penalties under the EAR and ITAR — which also govern deemed exports — can be severe:
Statutory Penalty Ranges
Recent Enforcement Examples
These cases illustrate the scale and seriousness of modern export control enforcement — even in technology sectors:
These outcomes underscore how export control enforcement now affects companies operating on the front lines of high-tech innovation, including those in AI, semiconductor, advanced software, and adjacent sectors.
Why Immigration + Regulatory Compliance Is Now Crucial
Traditionally, immigration compliance has focused on:
However, in today’s enforcement climate, immigration compliance cannot be siloed from export and national security regulations. Key driving factors include:
1. Interagency Coordination Is Increasing
Immigration, export control, and national security agencies increasingly share data and collaborate on enforcement, meaning an export compliance lapse associated with an immigration filing can trigger cross-agency scrutiny.
2. Sensitive Technologies Are Priority Enforcement Areas
Regulators have made clear that emerging technology sectors — including AI, advanced semiconductors, dual-use software, encryption, and HealthTech systems — are high priorities for export enforcement.
3. Penalties and Reputational Impact Are Material
Severe penalties can include:
4. M&A, Investment, and Funding Due Diligence
Investors and acquirers increasingly evaluate export compliance frameworks as part of diligence, particularly for companies in AI and HealthTech. Export compliance gaps may negatively impact valuations or deal timelines.
Practical Steps for Employers
Employers in technology-driven industries should take proactive measures:
Bottom Line
For companies in AI, HealthTech, semiconductor, and other cutting-edge technology sectors, deemed export compliance is not a peripheral obligation — it is a central regulatory risk tied to both talent mobility and core business operations. Employers must integrate immigration strategy with export control compliance to safeguard innovation, minimize regulatory exposure, and support long-term growth.
This communication is not intended to create or constitute, nor does it create or constitute, an attorney-client or any other legal relationship. No statement in this communication constitutes legal advice nor should any communication herein be construed, relied upon, or interpreted as legal advice. This communication is for general information purposes only regarding recent legal developments of interest, and is not a substitute for legal counsel on any subject matter. No reader should act or refrain from acting on the basis of any information included herein without seeking appropriate legal advice on the particular facts and circumstances affecting that reader. For more information, visit www.buchalter.com.